[Endomirabil, a new contrast medium for the biliary tract. Rate of adverse effects with special reference to the application time].
D000368:Aged; D000553:Ambulatory Care; D002758:Cholangiography; D006801:Humans; D007463:Iodobenzoates / Q000009:adverse effects*; D008536:Meglumine / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D013012:Sorbitol / Q000031:analogs & derivatives*; D013997:Time Factors; D014283:Triiodobenzoic Acids / Q000008:administration & dosage / Q000009:adverse effects*
D007463:Iodobenzoates; D014283:Triiodobenzoic Acids; D013012:Sorbitol; D008536:Meglumine
Endomirabil, ein neues gallengängiges Kontrastmittel. Nebenwirkungsrate unter besonderer Berücksichtigung der Applikationszeit